The Impact of AI on Clinical Trials: Four Key Benefits and Three Major Risks
August 1, 2025 | AI, Patient Retention, clinical trials, patient recruitment
Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which will inevitably aid regulatory decision-making.
Eloise Moffatt, our Vice President of Commercial, joined other industry experts during a webinar about AI trends and technologies for 2025. They discussed the benefits that AI and machine learning (ML) can bring to clinical trials and the potential pitfalls that require careful consideration.
Read more here
This content was provided by Innovative Trials